Stay updated on Empagliflozin US Comparative Effectiveness Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin US Comparative Effectiveness Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows minor layout and formatting updates to the Study Details section; no core study content or critical fields appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:26:35.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Added a government funding notice and an updated version tag (v3.2.0); removed the previous version tag (v3.1.0).
    Difference
    4%
    Check dated 2025-10-05T12:51:12.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. This indicates an updated release, but no other substantive content changes are evident.
    Difference
    0.1%
    Check dated 2025-09-28T09:33:00.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No other substantive content changes are evident in the additions and deletions.
    Difference
    0.3%
    Check dated 2025-09-14T00:10:34.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.3%
    Check dated 2025-09-06T21:08:32.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as new topics related to diabetes and pharmacologic actions. Notably, the previous version's references to specific location details and certain pharmacological terms have been removed.
    Difference
    4%
    Check dated 2025-08-30T15:31:16.000Z thumbnail image

Stay in the know with updates to Empagliflozin US Comparative Effectiveness Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin US Comparative Effectiveness Clinical Trial page.